Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis
Open Access
- 24 July 2008
- journal article
- research article
- Published by Wiley in The EMBO Journal
- Vol. 27 (16) , 2181-2193
- https://doi.org/10.1038/emboj.2008.149
Abstract
The atypical PKC‐interacting protein, Par‐4, inhibits cell survival and tumorigenesis in vitro , and its genetic inactivation in mice leads to reduced lifespan, enhanced benign tumour development and low‐frequency carcinogenesis. Here, we demonstrate that Par‐4 is highly expressed in normal lung but reduced in human lung cancer samples. We show, in a mouse model of lung tumours, that the lack of Par‐4 dramatically enhances Ras‐induced lung carcinoma formation in vivo , acting as a negative regulator of Akt activation. We also demonstrate in cell culture, in vivo , and in biochemical experiments that Akt regulation by Par‐4 is mediated by PKCζ, establishing a new paradigm for Akt regulation and, likely, for Ras‐induced lung carcinogenesis, wherein Par‐4 is a novel tumour suppressor.Keywords
This publication has 41 references indexed in Scilit:
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- BAFF controls B cell metabolic fitness through a PKCβ- and Akt-dependent mechanismThe Journal of Experimental Medicine, 2006
- Nuclear factor-κB in cancer development and progressionNature, 2006
- Identification of a tumour suppressor network opposing nuclear Akt functionNature, 2006
- NF‐κB and cancer: Mechanisms and targetsMolecular Carcinogenesis, 2006
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- ZIP Kinase Triggers Apoptosis from Nuclear PML Oncogenic DomainsMolecular and Cellular Biology, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- The Hallmarks of CancerCell, 2000
- Interaction partners of Dlk/ZIP kinase: co-expression of Dlk/ZIP kinase and Par-4 results in cytoplasmic retention and apoptosisOncogene, 1999